Search Results
Jun 29, 2026, 08:33 ET Consano Bio Highlights Scientific Advisory Board for C-1101, a Potential First-in-Class, Non-Opioid Therapy in Development for Chronic Sciatica
transfusion medicine, donor health, and blood-based therapeutic science.Li Malmberg, PhD, a veteran chemistry, manufacturing, and controls (CMC) executive with nearly 30 years of experience in biologics development and manufacturing."I am thrilled to be part of Consano Bio's Scientific
More news about: Consano Bio
Jun 26, 2026, 16:00 ET Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical safety or efficacy concerns were identified that impact approvability Sobi to meet
More news about: Swedish Orphan Biovitrum AB
Jun 26, 2026, 15:59 ET Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical safety or efficacy concerns were identified that impact approvability Sobi to meet
More news about: Swedish Orphan Biovitrum AB
Jun 25, 2026, 06:45 ET CMC Reports Third Quarter of Fiscal 2026 Results
"Investors."About CMCCMC is a Fortune 500 company headquartered in Irving, Texas, and a leading provider of early-stage construction solutions that support the foundational phases of modern infrastructure and building projects. Founded in 1915, CMC has grown from a single-site
More news about: CMC
Jun 24, 2026, 08:34 ET CMC Announces Quarterly Dividend of $0.20 Per Share
June 24, 2026 /PRNewswire/ -- Today, June 24, 2026, the board of directors of CMC (NYSE: CMC) declared a regular quarterly cash dividend of $0.20 per share of CMC common stock. CMC's 247th consecutive quarterly dividend will be paid on July 15, 2026, to stockholders of record
More news about: CMC
Jun 24, 2026, 08:00 ET Phosphorex to Host a Virtual Panel Discussion Exploring Targeted Lipid Nanoparticle Development for Extrahepatic Delivery
span lipid nanoparticle (LNP), polymeric nanoparticle (PNP), and polymeric microsphere formulation and process development, analytical expertise, and CMC strategy, supporting therapeutic programs across nucleic acid delivery, targeted therapy, and long-acting injectable applications from early development
More news about: Phosphorex LLC
Jun 23, 2026, 09:11 ET Wheeler Bio Launches New Website Reflecting Expansion of Capabilities, Clients Served, and a Commitment to High-Science, High-Touch Biologics Manufacturing
development strategies. By aligning development strategy with regulatory expectations and program objectives, ModularCMC™ helps sponsors streamline CMC execution and reduce development timelines for antibody-based therapeutics, including mAbs, multispecifics, Fc-fusion proteins, and antibody-drug conjugates.In
More news about: Wheeler Bio, Inc.
Jun 22, 2026, 20:00 ET AH-008 Achieves Dual Regulatory Milestones with U.S. FDA IND Clearance and Taiwan CDE Index Case Designation
company's integrated development capabilities. This accelerated timeline reflects AnHorn's ability to unify translational science, regulatory strategy, and CMC development into a streamlined execution framework—demonstrating its strength in efficiently advancing first-in-class programs that address urgent unmet
More news about: AnHorn Medicines
Jun 22, 2026, 08:30 ET How to Prepare for a Successful Drug Marketing Application Submission, Upcoming Webinar Hosted by Xtalks
preparation. Attendees will gain insights into identifying and addressing potential gaps in critical data across chemistry, manufacturing and controls (CMC), nonclinical, clinical and geography-specific regulatory requirements. The session will also highlight key interactions with regulatory agencies and
More news about: Xtalks
Jun 22, 2026, 04:39 ET Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall
clinical evidence and patient value can withstand international scrutiny. Since its establishment, Innogen has continued to build its clinical development, CMC, quality management and pharmacovigilance systems in line with international technical expectations, with a focus on ICH guidelines, GCP, GMP, data integrity
More news about: Innogen Pharmaceuticals
Jun 19, 2026, 09:00 ET Fapon Biopharma and MOTE Therapeutics to Present Dual-Platform B-Cell Immunotherapy Franchise at BIO 2026
CDH17-targeting T-cell engager with a second co-stimulation signal for gastrointestinal tract cancers. Both FP012 and FPE021 are entering IND-enabling CMC/GLP toxicology in 2026.Attendees interested in the science behind these programs can gain deeper insights during a dedicated company presentation,
More news about: Fapon Biopharma
Jun 18, 2026, 08:00 ET Matica Biotechnology Launches Integrated Korea IIT Platform Solution to Accelerate Global Advanced Therapy Development
globally recognized Korean clinical execution with Matica Bio's U.S. based manufacturing, process development, analytical development, and translational CMC expertise.The launch comes at a pivotal time for the global advanced therapy industry as sponsors increasingly seek efficient, high-quality, and
More news about: Matica Biotechnology, Inc.
Jun 18, 2026, 06:55 ET IASO Bio Announces NDA Approval of Equecabtagene Autoleucel by the Singapore Health Sciences Authority (HSA) for the Treatment of Relapsed or Refractory Multiple Myeloma, Marking a Key Milestone in International Commercialization
capabilities.Leveraging our strong execution capability, an integrated and experienced management team in ATMPs, a robust pipeline, and advanced manufacturing and CMC capabilities, IASO Bio remains committed to making transformative cell therapies broadly accessible to patients worldwide.
More news about: IASO Bio
Jun 17, 2026, 08:10 ET OCuSOFT Inc. Introduces Retaine® Ultra PF™
products including not only the OLS hygiene group but also Retaine® MGD™ Advanced™ preservative-free artificial tears, Retaine® CMC®, HypoChlor® Spray, and many others. OCuSOFT Inc. established the Southwest Research & Technology Center which houses numerous eye
More news about: OCuSOFT Inc.
Jun 16, 2026, 10:13 ET IDBS and Alchemi partner to accelerate biopharma regulatory filings with compliant AI agents
Preparing regulatory filings remains one of biopharma's most persistent bottlenecks. CMC teams spend months assembling data, drafting reports and reconstructing process histories, while current AI tools often break the compliance chain by
More news about: IDBS
Jun 16, 2026, 08:00 ET Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Development (LED3) Scientific Conference
it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC (Chemistry Manufacturing and Controls) information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase
More news about: Acurx Pharmaceuticals, Inc.
Jun 15, 2026, 10:30 ET Stem Cell Therapy Market worth $3.65 billion by 2035 | MarketsandMarkets™
donor-cell expansion, batch-to-batch comparability, and long-term cell viability are essential for off-the-shelf product supply. Evolving GMP requirements, CMC expectations, donor eligibility standards, sterility controls, potency assay requirements, traceability systems, and post-market safety monitoring frameworks
More news about: MarketsandMarkets
Jun 11, 2026, 12:00 ET GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
for the treatment of patients with aSAH." According to the Company, "the FDA referenced certain items in the Chemistry, Manufacturing, and Controls (CMC) and Non-Clinical sections of the application," which "are related to leachables data for product packaging, non-clinical product toxicology risk assessments,
More news about: The Schall Law Firm
Jun 11, 2026, 02:20 ET CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
(head-to-head vs. pembrolizumab) .20–60 patients of POC data are expected per indication. The company has already established a clinical, CMC (Chemistry, Manufacturing and Controls) and operational system that supports global development, laying the groundwork for subsequent global multi-center
More news about: CStone Pharmaceuticals
Jun 11, 2026, 00:13 ET Pearl Studio and CMC Pictures Set Global Summer Release for Animated Comedy Feature All Wishes Come True!
global audiences in the future.About CMCCMC Pictures is the film platform of CMC Inc., engaged in development, production, investment, marketing, and domestic and international distribution. As one of the leading film companies in China, CMC Pictures partners range from top-notch domestic
More news about: CMC Pictures
Jun 09, 2026, 00:13 ET Baidu Responds to Inclusion on U.S. CMC List
Military Companies (the "CMC List"). As the Company is neither a Chinese military company nor a military-civil fusion contributor to the Chinese defense industrial base, the Company believes that there is no justification for the Company's inclusion on such list.The CMC List is not a sanctions
More news about: Baidu, Inc.
Jun 08, 2026, 12:51 ET GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
for the treatment of patients with aSAH." According to the Company, "the FDA referenced certain items in the Chemistry, Manufacturing, and Controls (CMC) and Non-Clinical sections of the application," which "are related to leachables data for product packaging, non-clinical product toxicology risk assessments,
More news about: The Schall Law Firm
Jun 08, 2026, 03:20 ET TARS Brings Real-Life Embodied AI to ICRA 2026 Robotics Conference
conventional parallel-joint designs that introduce kinematic distortion during complex movements, DexHand replicates the spatial convergence of the thumb's CMC and MCP joints, eliminating the motion blind spots. Its self-developed joints integrate high-precision reducers, reducing backlash to an extremely small
More news about: TARS
Jun 08, 2026, 03:20 ET TARS Brings Real-Life Embodied AI to ICRA 2026 Robotics Conference
conventional parallel-joint designs that introduce kinematic distortion during complex movements, DexHand replicates the spatial convergence of the thumb's CMC and MCP joints, eliminating the motion blind spots. Its self-developed joints integrate high-precision reducers, reducing backlash to an extremely small
More news about: TARS
Jun 08, 2026, 03:20 ET TARS präsentiert auf der ICRA 2026 Robotics Conference realitätsnahe, verkörperte KI
Konstruktionen mit parallelen Gelenken, bei denen es bei komplexen Bewegungen zu kinematischen Verzerrungen kommt, bildet DexHand die räumliche Konvergenz der CMC- und MCP-Gelenke des Daumens nach und beseitigt so die Bewegungsblindstellen. Die eigens entwickelten Gelenke verfügen über hochpräzise Untersetzungsgetriebe,
More news about: TARS